PU.1 Expression Defines Distinct Functional Activities in the Phenotypic HSC Compartment of a Murine Inflammatory Stress Model

• Published in: Cells (Basel, Switzerland) Vol. 11; no. 4; p. 680
• Main Authors: Chavez, James S, Rabe, Jennifer L, Hernandez, Giovanny, Mills, Taylor S, Niño, Katia E, Davizon-Castillo, Pavel, Pietras, Eric M
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 15.02.2022; MDPI
• Subjects: Animals; Antibiotics; Antibodies; CD150 antigen; Cell cycle; Cytokines; Flow cytometry; hematopoiesis; hematopoietic stem cell; Hematopoietic stem cells; Hematopoietic Stem Cells - metabolism; IL-1β; Inflammation; megakaryocyte; Mice; myeloid; Physiology; Progenitor cells; PU.1; PU.1 protein; Stem cell transplantation; Stem cells; Surface markers; Transcription factors; Transplants & implants; St Louis Missouri; United States > US; hematopoietic stem cell; megakaryocyte; hematopoiesis; myeloid; inflammation; PU.1
• ISSN: 2073-4409; 2073-4409
• DOI: 10.3390/cells11040680

The transcription factor PU.1 is a critical regulator of lineage fate in blood-forming hematopoietic stem cells (HSC). In response to pro-inflammatory signals, such as the cytokine IL-1β, PU.1 expression is increased in HSC and is associated with myeloid lineage expansion. To address potential functional heterogeneities arising in the phenotypic HSC compartment due to changes in PU.1 expression, here, we fractionated phenotypic HSC in mice using the SLAM surface marker code in conjunction with PU.1 expression levels, using the reporter mouse strain. While PU.1 SLAM cells contain extensive long-term repopulating activity and a molecular signature corresponding to HSC activity at steady state, following IL-1β treatment, HSC induce PU.1 expression and are replaced in the PU.1 SLAM fraction by CD41 HSC-like megakaryocytic progenitors (SL-MkP) with limited long-term engraftment capacity. On the other hand, the PU.1 SLAM fraction exhibits extensive myeloid lineage priming and clonogenic activity and expands rapidly in response to IL-1β. Furthermore, we show that EPCR expression, but not CD150 expression, can distinguish HSC and SL-MkP under inflammatory conditions. Altogether, our data provide insights into the dynamic regulation of PU.1 and identify how PU.1 levels are linked to HSC fate in steady state and inflammatory stress conditions.